Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s15010-020-01474-9 http://scihub22266oqcxt.onion/10.1007/s15010-020-01474-9 32725597!7386387!32725597     free     free     free Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infection 2021 ; 49 (1): 153-157 Nephropedia Template TP {{tp|p=32725597|t=2021. Pulmonary function in patients surviving to COVID-19 pneumonia |pdf=|usr=}}{{32725597}} gab.com Text Pulmonary function in patients surviving to COVID-19 pneumonia JO: Infection http://www.kidney.de/pget.php?&tw=1&pmid=32725597 #FOAvip PURPOSE: The aim of our study was to assess respiratory function at the time of clinical recovery and 6 weeks after discharge in patients surviving to COVID-19 pneumonia. METHODS: Our case series consisted of 13 patients with COVID-19 pneumonia. RESULTS: At the time of clinical recovery, FEV1 (2.07 +/- 0.72 L) and FVC (2.25 +/- 0.86 L) were lower compared to lower limit of normality (LLN) values (2.56 +/- 0.53 L, p = 0.004, and 3.31 +/- 0.65 L, p < 0.001, respectively), while FEV1/FVC (0.94 +/- 0.07) was higher compared to upper limit of normality (ULN) values (0.89 +/- 0.01, p = 0.029). After 6 weeks pulmonary function improved but FVC was still lower than ULN (2.87 +/- 0.81, p = 0.014). CONCLUSION: These findings suggest that COVID-19 pneumonia may result in clinically relevant alterations in pulmonary function tests, with a mainly restrictive pattern. Twit Text FOAVip Pulmonary function in patients surviving to COVID-19 pneumonia ????Infection http://www.kidney.de/pget.php?&tw=1&pmid=32725597 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32725597 #FOAvip English Wikipedia <ref>{{Cite pmid|32725597}}</ref> Pulmonary function in patients surviving to COVID-19 pneumonia #MMPMID32725597 Fumagalli A; Misuraca C; Bianchi A; Borsa N; Limonta S; Maggiolini S; Bonardi DR; Corsonello A; Di Rosa M; Soraci L; Lattanzio F; Colombo D Infection 2021[Feb]; 49 (1): 153-157 PMID32725597show ga PURPOSE: The aim of our study was to assess respiratory function at the time of clinical recovery and 6 weeks after discharge in patients surviving to COVID-19 pneumonia. METHODS: Our case series consisted of 13 patients with COVID-19 pneumonia. RESULTS: At the time of clinical recovery, FEV1 (2.07 +/- 0.72 L) and FVC (2.25 +/- 0.86 L) were lower compared to lower limit of normality (LLN) values (2.56 +/- 0.53 L, p = 0.004, and 3.31 +/- 0.65 L, p < 0.001, respectively), while FEV1/FVC (0.94 +/- 0.07) was higher compared to upper limit of normality (ULN) values (0.89 +/- 0.01, p = 0.029). After 6 weeks pulmonary function improved but FVC was still lower than ULN (2.87 +/- 0.81, p = 0.014). CONCLUSION: These findings suggest that COVID-19 pneumonia may result in clinically relevant alterations in pulmonary function tests, with a mainly restrictive pattern. |Adult[MESH] |Aged[MESH] |COVID-19/diagnosis/pathology/*physiopathology/virology[MESH] |Cough/diagnosis/pathology/*physiopathology/virology[MESH] |Dyspnea/diagnosis/pathology/*physiopathology/virology[MESH] |Female[MESH] |Fever/diagnosis/pathology/*physiopathology/virology[MESH] |Humans[MESH] |Lung/diagnostic imaging/pathology/*physiopathology/virology[MESH] |Male[MESH] |Middle Aged[MESH] |Respiratory Function Tests[MESH] |SARS-CoV-2/*pathogenicity[MESH] |Spirometry[MESH]Pulmonary function in patients surviving to COVID-19 pneumonia (epmc).pdf DeepDyve Pubget Overpricing